Answers are grounded in this paper and cite their sources.
We identified and validated a 13-gene signature that is considerably better than tumor stage in predicting survival of patients with HPV-negative OSCCs. Further evaluation of this gene signature as a prognostic marker in other populations of patients with HPV-negative OSCC is warranted.
No takes yet. Share an insight, caveat, or question.
Lohavanichbutr et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: